Responses ( complete response and partial response ) were seen in 36 % of doxorubicin , 34 % of paclitaxel , and 47 % of AT patients ( P = .84 for doxorubicin v paclitaxel , P = .007 for v AT , P = .004 for paclitaxel v AT ) .
